Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 8.58
+0.18 (2.14%)
Last updated: Jan 22, 2026, 10:07 AM CET
Svas Biosana Market Cap
Svas Biosana has a market cap or net worth of €45.17 million as of January 22, 2026. Its market cap has increased by 15.40% in one year.
Market Cap
45.17M
Enterprise Value
90.09M
Revenue
134.95M
Ranking
n/a
PE Ratio
6.70
Stock Price
€8.58
Market Cap Chart
Since December 9, 2021, Svas Biosana's market cap has decreased from 81.14M to 45.17M, a decrease of -44.34%. That is a compound annual growth rate of -13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 44.63M | 5.00% |
| Dec 30, 2025 | 42.51M | 10.91% |
| Dec 30, 2024 | 38.33M | -11.25% |
| Dec 29, 2023 | 43.19M | -20.87% |
| Dec 30, 2022 | 54.58M | -37.13% |
| Dec 30, 2021 | 86.80M | 6.97% |
| Dec 9, 2021 | 81.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 9.71B |
| DiaSorin | 4.01B |
| Amplifon | 2.95B |
| EL.En. | 1.12B |
| GPI S.p.A. | 473.77M |
| Health Italia | 55.53M |
| Talea Group | 40.74M |
| Farmacosmo | 24.92M |